{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T02:32:25Z","timestamp":1787970745843,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10863-024-10006-1","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T07:02:00Z","timestamp":1707202920000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner"],"prefix":"10.1007","volume":"56","author":[{"given":"Zengyao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"issue":"3","key":"10006_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","volume":"6","author":"MC Bahit","year":"2018","unstructured":"Bahit MC, Kochar A, Granger CB (2018) Post-myocardial infarction heart failure. JACC Heart Fail 6(3):179\u2013186. https:\/\/doi.org\/10.1016\/j.jchf.2017.09.015","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10006_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ejhf.1672","volume":"22","author":"T Berulava","year":"2020","unstructured":"Berulava T, Buchholz E, Elerdashvili V, Pena T, Islam MR, Lbik D et al (2020) Changes in m6A RNA methylation contribute to heart failure progression by modulating translation. Eur J Heart Fail 22(1):54\u201366. https:\/\/doi.org\/10.1002\/ejhf.1672","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10006_CR3","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","volume":"17","author":"BA Borlaug","year":"2020","unstructured":"Borlaug BA (2020) Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol 17(9):559\u2013573. https:\/\/doi.org\/10.1038\/s41569-020-0363-2","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10006_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbrc.2019.06.015","volume":"516","author":"X Chen","year":"2019","unstructured":"Chen X, Xu S, Zhao C, Liu B (2019) Role of TLR4\/NADPH oxidase 4 pathway in promoting cell death through autophagy and ferroptosis during heart failure. Biochem Biophys Res Commun 516(1):37\u201343. https:\/\/doi.org\/10.1016\/j.bbrc.2019.06.015","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10006_CR5","doi-asserted-by":"publisher","first-page":"e2025070118","DOI":"10.1073\/pnas.2025070118","volume":"118","author":"CS Chien","year":"2021","unstructured":"Chien CS, Li JY, Chien Y, Wang ML, Yarmishyn AA, Tsai PH et al (2021) METTL3-dependent N6-methyladenosine RNA modification mediates the atherogenic inflammatory cascades in vascular endothelium. Proc Natl Acad Sci U S A 118(7):e2025070118. https:\/\/doi.org\/10.1073\/pnas.2025070118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10006_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10741-019-09821-1","volume":"25","author":"MS Cruz","year":"2020","unstructured":"Cruz MS, da Silva AMG, de Souza KSC, Luchessi AD, Silbiger VN (2020) miRNAs emerge as circulating biomarkers of post-myocardial infarction heart failure. Heart Fail Rev 25(2):321\u2013329. https:\/\/doi.org\/10.1007\/s10741-019-09821-1","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10006_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re DP, Amgalan D, Linkermann A, Liu Q, Kitsis RN (2019) Fundamental mechanisms of regulated cell death and implications for Heart Disease. Physiol Rev 99(4):1765\u20131817. https:\/\/doi.org\/10.1152\/physrev.00022.2018","journal-title":"Physiol Rev"},{"issue":"2","key":"10006_CR8","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","volume":"11","author":"D Dixit","year":"2021","unstructured":"Dixit D, Prager BC, Gimple RC, Poh HX, Wang Y, Wu Q et al (2021) The RNA m6A reader YTHDF2 maintains Oncogene expression and is a targetable dependency in Glioblastoma Stem cells. Cancer Discov 11(2):480\u2013499. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0331","journal-title":"Cancer Discov"},{"issue":"4","key":"10006_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/CIRCULATIONAHA.118.036146","volume":"139","author":"LE Dorn","year":"2019","unstructured":"Dorn LE, Lasman L, Chen J, Xu X, Hund TJ, Medvedovic M et al (2019) The N6-Methyladenosine mRNA methylase METTL3 controls Cardiac Homeostasis and Hypertrophy. Circulation 139(4):533\u2013545. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.036146","journal-title":"Circulation"},{"issue":"21","key":"10006_CR10","doi-asserted-by":"publisher","first-page":"10197","DOI":"10.1111\/jcmm.16957","volume":"25","author":"Z Fan","year":"2021","unstructured":"Fan Z, Yang G, Zhang W, Liu Q, Liu G, Liu P et al (2021) Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11. J Cell Mol Med 25(21):10197\u201310212. https:\/\/doi.org\/10.1111\/jcmm.16957","journal-title":"J Cell Mol Med"},{"issue":"7","key":"10006_CR12","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J et al (2019) Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A 116(7):2672\u20132680. https:\/\/doi.org\/10.1073\/pnas.1821022116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10006_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","volume":"127","author":"X Fang","year":"2020","unstructured":"Fang X, Cai Z, Wang H, Han D, Cheng Q, Zhang P et al (2020) Loss of Cardiac Ferritin H facilitates Cardiomyopathy via Slc7a11-Mediated ferroptosis. Circ Res 127(4):486\u2013501. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316509","journal-title":"Circ Res"},{"key":"10006_CR13","doi-asserted-by":"publisher","first-page":"118660","DOI":"10.1016\/j.lfs.2020.118660","volume":"264","author":"X Guan","year":"2021","unstructured":"Guan X, Li Z, Zhu S, Cheng M, Ju Y, Ren L et al (2021) Galangin attenuated cerebral ischemia-reperfusion injury by inhibition of ferroptosis through activating the SLC7A11\/GPX4 axis in gerbils. Life Sci 264:118660. https:\/\/doi.org\/10.1016\/j.lfs.2020.118660","journal-title":"Life Sci"},{"key":"10006_CR14","doi-asserted-by":"publisher","first-page":"710963","DOI":"10.3389\/fcvm.2021.710963","volume":"8","author":"H Hu","year":"2021","unstructured":"Hu H, Chen Y, Jing L, Zhai C, Shen L (2021) The Link between Ferroptosis and Cardiovascular diseases: a novel target for treatment. Front Cardiovasc Med 8:710963. https:\/\/doi.org\/10.3389\/fcvm.2021.710963","journal-title":"Front Cardiovasc Med"},{"key":"10006_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/5584_2018_149","volume":"1067","author":"AM Ilie\u0219iu","year":"2018","unstructured":"Ilie\u0219iu AM, Hodorogea AS (2018) Treatment of Heart failure with preserved ejection fraction. Adv Exp Med Biol 1067:67\u201387. https:\/\/doi.org\/10.1007\/5584_2018_149","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10006_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.13144","volume":"8","author":"D Jen\u010da","year":"2021","unstructured":"Jen\u010da D, Melenovsk\u00fd V, Stehlik J, Stan\u011bk V, Kettner J, Kautzner J et al (2021) Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail 8(1):222\u2013237. https:\/\/doi.org\/10.1002\/ehf2.13144","journal-title":"ESC Heart Fail"},{"issue":"8","key":"10006_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B (2021) Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8):599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5","journal-title":"Protein Cell"},{"key":"10006_CR18","doi-asserted-by":"publisher","first-page":"105466","DOI":"10.1016\/j.phrs.2021.105466","volume":"166","author":"N Li","year":"2021","unstructured":"Li N, Jiang W, Wang W, Xiong R, Wu X, Geng Q (2021) Ferroptosis and its emerging roles in cardiovascular diseases. Pharmacol Res 166:105466. https:\/\/doi.org\/10.1016\/j.phrs.2021.105466","journal-title":"Pharmacol Res"},{"issue":"10","key":"10006_CR19","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.7150\/ijbs.72528","volume":"18","author":"N Li","year":"2022","unstructured":"Li N, Yi X, He Y, Huo B, Chen Y, Zhang Z et al (2022) Targeting Ferroptosis as a Novel Approach to alleviate aortic dissection. Int J Biol Sci 18(10):4118\u20134134. https:\/\/doi.org\/10.7150\/ijbs.72528","journal-title":"Int J Biol Sci"},{"issue":"3","key":"10006_CR20","doi-asserted-by":"publisher","first-page":"e22147","DOI":"10.1096\/fj.202101610R","volume":"36","author":"Y Lin","year":"2022","unstructured":"Lin Y, Shen X, Ke Y, Lan C, Chen X, Liang B et al (2022) Activation of osteoblast ferroptosis via the METTL3\/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss. FASEB J 36(3):e22147. https:\/\/doi.org\/10.1096\/fj.202101610R","journal-title":"FASEB J"},{"key":"10006_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.freeradbiomed.2021.01.033","volume":"165","author":"WQ Ma","year":"2021","unstructured":"Ma WQ, Sun XJ, Zhu Y, Liu NF (2021) Metformin attenuates hyperlipidaemia-associated vascular calcification through anti-ferroptotic effects. Free Radic Biol Med 165:229\u2013242. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.01.033","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"10006_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ejhf.640","volume":"19","author":"V Melenovsky","year":"2017","unstructured":"Melenovsky V, Petrak J, Mracek T, Benes J, Borlaug BA, Nuskova H et al (2017) Myocardial iron content and mitochondrial function in human heart failure: a direct tissue analysis. Eur J Heart Fail 19(4):522\u2013530. https:\/\/doi.org\/10.1002\/ejhf.640","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10006_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","volume":"139","author":"A Pietrangelo","year":"2010","unstructured":"Pietrangelo A (2010) Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology 139(2):393\u2013408. 408.e1-2","journal-title":"Gastroenterology"},{"issue":"6","key":"10006_CR24","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3892\/ijmm.2020.4746","volume":"46","author":"Y Qin","year":"2020","unstructured":"Qin Y, Li L, Luo E, Hou J, Yan G, Wang D et al (2020) Role of m6A RNA methylation in cardiovascular disease (review). Int J Mol Med 46(6):1958\u20131972. https:\/\/doi.org\/10.3892\/ijmm.2020.4746","journal-title":"Int J Mol Med"},{"key":"10006_CR25","doi-asserted-by":"publisher","first-page":"119366","DOI":"10.1016\/j.lfs.2021.119366","volume":"274","author":"Y Qin","year":"2021","unstructured":"Qin Y, Qiao Y, Li L, Luo E, Wang D, Yao Y et al (2021) The m6A methyltransferase METTL3 promotes hypoxic pulmonary arterial hypertension. Life Sci 274:119366. https:\/\/doi.org\/10.1016\/j.lfs.2021.119366","journal-title":"Life Sci"},{"key":"10006_CR26","doi-asserted-by":"publisher","first-page":"104919","DOI":"10.1016\/j.phrs.2020.104919","volume":"159","author":"Y Qiu","year":"2020","unstructured":"Qiu Y, Cao Y, Cao W, Jia Y, Lu N (2020) The application of ferroptosis in diseases. Pharmacol Res 159:104919. https:\/\/doi.org\/10.1016\/j.phrs.2020.104919","journal-title":"Pharmacol Res"},{"issue":"6","key":"10006_CR27","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ehf2.12555","volume":"6","author":"D Tomasoni","year":"2019","unstructured":"Tomasoni D, Adamo M, Lombardi CM, Metra M (2019) Highlights in heart failure. ESC Heart Fail 6(6):1105\u20131127. https:\/\/doi.org\/10.1002\/ehf2.12555","journal-title":"ESC Heart Fail"},{"issue":"15","key":"10006_CR28","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.3390\/cells11152271","volume":"11","author":"M Vausort","year":"2022","unstructured":"Vausort M, Niedolistek M, Lumley AI, Okni\u0144ska M, Paterek A, M\u0105czewski M et al (2022) Regulation of N6-Methyladenosine after myocardial infarction. Cells 11(15):2271. https:\/\/doi.org\/10.3390\/cells11152271","journal-title":"Cells"},{"issue":"3","key":"10006_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2015.158","volume":"23","author":"Y Xie","year":"2016","unstructured":"Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X et al (2016) Ferroptosis: process and function. Cell Death Differ 23(3):369\u2013379. https:\/\/doi.org\/10.1038\/cdd.2015.158","journal-title":"Cell Death Differ"},{"issue":"1","key":"10006_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12935-021-02433-6","volume":"22","author":"Y Xu","year":"2022","unstructured":"Xu Y, Lv D, Yan C, Su H, Zhang X, Shi Y et al (2022) METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m6A modification. Cancer Cell Int 22(1):11. https:\/\/doi.org\/10.1186\/s12935-021-02433-6","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10006_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41420-021-00579-w","volume":"7","author":"Y Yu","year":"2021","unstructured":"Yu Y, Yan Y, Niu F, Wang Y, Chen X, Su G et al (2021) Ferroptosis: a cell death connecting oxidative stress, inflammation and cardiovascular diseases. Cell Death Discov 7(1):193. https:\/\/doi.org\/10.1038\/s41420-021-00579-w","journal-title":"Cell Death Discov"},{"key":"10006_CR32","doi-asserted-by":"publisher","first-page":"647806","DOI":"10.3389\/fcvm.2021.647806","volume":"8","author":"B Zhang","year":"2021","unstructured":"Zhang B, Xu Y, Cui X, Jiang H, Luo W, Weng X et al (2021) Alteration of m6A RNA methylation in heart failure with preserved ejection fraction. Front Cardiovasc Med 8:647806. https:\/\/doi.org\/10.3389\/fcvm.2021.647806","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10006_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10557-021-07220-z","volume":"36","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zheng C, Gao Z, Chen H, Li K, Wang L et al (2022) SLC7A11\/xCT prevents Cardiac Hypertrophy by inhibiting ferroptosis. Cardiovasc Drugs Ther 36(3):437\u2013447. https:\/\/doi.org\/10.1007\/s10557-021-07220-z","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10006_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13045-020-00872-8","volume":"13","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Shi Y, Shen H, Xie W (2020) m6A-binding proteins: the emerging crucial performers in epigenetics. J Hematol Oncol 13(1):35. https:\/\/doi.org\/10.1186\/s13045-020-00872-8","journal-title":"J Hematol Oncol"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-024-10006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10863-024-10006-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-024-10006-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T03:33:11Z","timestamp":1712287991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10863-024-10006-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10006"],"URL":"https:\/\/doi.org\/10.1007\/s10863-024-10006-1","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"25 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}